Bio-Rad Laboratories | BIO - Ebitda


Bio-Rad Laboratories reported $467.2M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Agilent USD 466M 5M Jun/2025
Becton, Dickinson and Co. USD 2.15B 674M Sep/2025
Bio Techne USD 95.94M 19.64M Sep/2025
Bio-Rad Laboratories USD 467.2M 372.2M Jun/2025
Bruker USD 128.1M 27.1M Jun/2025
Charles River Laboratories USD 282.89M 64.81M Sep/2025
Danaher USD 2.13B 252M Dec/2025
Exact Sciences USD 135.42M 2.8M Sep/2025
General Electric Aerospace USD 3.04B 185M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
Illumina USD 332M 12M Sep/2025
IQVIA Holdings USD 949M 39M Sep/2025
Laboratory Of America USD 633.6M 135.6M Jun/2025
Merck USD 8.39B 1.97B Sep/2025
Mettler Toledo International USD 322.64M 26.75M Sep/2025
Myriad Genetics USD 10.3M 4.2M Sep/2025
Quest Diagnostics USD 561M 9M Sep/2025
Repligen USD 35.93M 3.75M Sep/2025
Revvity USD 248.91M 48.52M Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Siemens EUR 3.1B 459M Sep/2025
Standard Biotools USD -16.54M 2.26M Sep/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Tosoh JPY 39.13B 286M Dec/2024
Waters USD 295.14M 18.87M Sep/2025